BackRelmada Therapeutics Overview
Relmada Therapeutics Inc

Relmada Therapeutics Target Price

Relmada Therapeutics target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.17

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-18H.C. Wainwright$12187.8% upsideOpen
2026-03-13Mizuho SecuritiesUy Ear$10139.8% upsideOpen
2026-01-23Leerink Partners$891.8% upsideOpen
2025-12-22Jefferies$9115.8% upsideOpen
2024-06-05Goldman SachsAndrea Tan$252% downsideOpen
2022-10-13JefferiesAndrew Tsai$891.8% upsideOpen
2022-10-13OppenheimerJay Olson$767.9% upsideOpen

Relmada Therapeutics (RLMD) FAQ

Stockcircle tracks target price for Relmada Therapeutics (RLMD), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Relmada Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main RLMD overview so you can move from this figure to the surrounding analysis quickly.